Curve Therapeutics
biotech · Southampton, GB
Southampton biotech with an intracellular screening platform (Microcycle) for cancer drug discovery.
Funding history
| Date | Round | Amount |
|---|
| Feb 2024 | Series A Curve Therapeutics closed a £40.5M Series A led by Pfizer Ventures to accelerate its cancer drug candidates toward human trials. | $51M |
Investors
Advent Life SciencesBritish Patient CapitalColumbus Venture PartnersEpidarex CapitalPfizer Ventures
Similar companies in biotech
Explore funding flow on EquityFlow →